Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

Bhatt, Deepak L; Szarek, Michael; Pitt, Bertram; Cannon, Christopher P; Leiter, Lawrence A; McGuire, Darren K; Lewis, Julia B; Riddle, Matthew C; Inzucchi, Silvio E; Kosiborod, Mikhail N; Cherney, David Z I; Dwyer, Jamie P; Scirica, Benjamin M; Bailey, Clifford J; Díaz, Rafael; Ray, Kausik K; Udell, Jacob A; Lopes, Renato D; Lapuerta, Pablo; Steg, P Gabriel.

N Engl J Med ; 384(2): 129-139, 2021 01 14.

Artículo en Inglés | MEDLINE | ID: mdl-33200891

2.

Metformin: Therapeutic profile in the treatment of type 2 diabetes.

Bailey, Clifford J.

Diabetes Obes Metab ; 2024 May 24.

Artículo en Inglés | MEDLINE | ID: mdl-38784991

3.

Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease.

Bailey, Clifford J; Day, Caroline; Bellary, Srikanth.

Curr Diab Rep ; 22(1): 39-52, 2022 01.

Artículo en Inglés | MEDLINE | ID: mdl-35113333

4.

From insulin injections to islet transplantation: An overview of the journey.

Paget, Michelle B; Murray, Hilary E; Bailey, Clifford J; Downing, Richard.

Diabetes Obes Metab ; 24 Suppl 1: 5-16, 2022 01.

Artículo en Inglés | MEDLINE | ID: mdl-34431589

5.

Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence.

Bailey, Clifford J; Gavin, James R.

Clin Diabetes ; 39(1): 64-71, 2021 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-33551555

6.

Vincent Marks (10 June 1930 to 6 November 2023).

Flatt, Peter R; Bailey, Clifford J.

Diabet Med ; 41(3): e15274, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-38130163

7.

Uric acid and the cardio-renal effects of SGLT2 inhibitors.

Bailey, Clifford J.

Diabetes Obes Metab ; 21(6): 1291-1298, 2019 06.

Artículo en Inglés | MEDLINE | ID: mdl-30762288

8.

Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials.

Bailey, Clifford J; Marx, Nikolaus.

Diabetes Obes Metab ; 21(1): 3-14, 2019 01.

Artículo en Inglés | MEDLINE | ID: mdl-30091169

9.

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes.

Bailey, Clifford J; Del Prato, Stefano; Wei, Cheryl; Reyner, Daniel; Saraiva, Gabriela.

Diabetes Obes Metab ; 21(11): 2564-2569, 2019 11.

Artículo en Inglés | MEDLINE | ID: mdl-31364269

10.

Rotational culture and integration with amniotic stem cells reduce porcine islet immunoreactivity in vitro and slow xeno-rejection in a murine model of islet transplantation.

Zafar, Ali; Lee, Jou; Yesmin, Shameema; Paget, Michelle B; Bailey, Clifford J; Murray, Hilary E; Downing, Richard.

Xenotransplantation ; 26(4): e12508, 2019 07.

Artículo en Inglés | MEDLINE | ID: mdl-30963627

11.

Treatment of type 2 diabetes: future approaches.

Bailey, Clifford J; Day, Caroline.

Br Med Bull ; 126(1): 123-137, 2018 06 01.

Artículo en Inglés | MEDLINE | ID: mdl-29897499

12.

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.

Jabbour, Serge; Seufert, Jochen; Scheen, Andre; Bailey, Clifford J; Karup, Cathrina; Langkilde, Anna M.

Diabetes Obes Metab ; 20(3): 620-628, 2018 03.

Artículo en Inglés | MEDLINE | ID: mdl-28950419

13.

Metformin: historical overview.

Bailey, Clifford J.

Diabetologia ; 60(9): 1566-1576, 2017 09.

Artículo en Inglés | MEDLINE | ID: mdl-28776081

14.

Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels.

Rana, Karan S; Pararasa, Chathyan; Afzal, Islam; Nagel, David A; Hill, Eric J; Bailey, Clifford J; Griffiths, Helen R; Kyrou, Ioannis; Randeva, Harpal S; Bellary, Srikanth; Brown, James E.

Cardiovasc Diabetol ; 16(1): 147, 2017 11 09.

Artículo en Inglés | MEDLINE | ID: mdl-29121940

15.

Metformin and the gastrointestinal tract.

McCreight, Laura J; Bailey, Clifford J; Pearson, Ewan R.

Diabetologia ; 59(3): 426-35, 2016 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-26780750

16.

Under-treatment of type 2 diabetes: Causes and outcomes of clinical inertia.

Bailey, Clifford J.

Int J Clin Pract ; 70(12): 988-995, 2016 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-28032429

17.

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Cosentino, Francesco; Grant, Peter J; Aboyans, Victor; Bailey, Clifford J; Ceriello, Antonio; Delgado, Victoria; Federici, Massimo; Filippatos, Gerasimos; Grobbee, Diederick E; Hansen, Tina Birgitte; Huikuri, Heikki V; Johansson, Isabelle; Jüni, Peter; Lettino, Maddalena; Marx, Nikolaus; Mellbin, Linda G; Östgren, Carl J; Rocca, Bianca; Roffi, Marco; Sattar, Naveed; Seferovic, Petar M; Sousa-Uva, Miguel; Valensi, Paul; Wheeler, David C.

Eur Heart J ; 41(2): 255-323, 2020 01 07.

Artículo en Inglés | MEDLINE | ID: mdl-31497854

18.

Ageing, adipose tissue, fatty acids and inflammation.

Pararasa, Chathyan; Bailey, Clifford J; Griffiths, Helen R.

Biogerontology ; 16(2): 235-48, 2015 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-25367746

19.

Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivity.

Qureshi, Khalid M; Lee, Jou; Paget, Michelle B; Bailey, Clifford J; Curnow, S John; Murray, Hilary E; Downing, Richard.

Clin Transplant ; 29(1): 90-8, 2015 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-25382449

20.

FDA guidance on cardiovascular risk of antidiabetic therapies: One decade later.

Bailey, Clifford J.

Diabetes Obes Metab ; 21(5): 1079-1080, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-30762280

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar:

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

Metformin: Therapeutic profile in the treatment of type 2 diabetes.

Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease.

From insulin injections to islet transplantation: An overview of the journey.

Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence.

Vincent Marks (10 June 1930 to 6 November 2023).

Uric acid and the cardio-renal effects of SGLT2 inhibitors.

Cardiovascular protection in type 2 diabetes: Insights from recent outcome trials.

Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes.

Rotational culture and integration with amniotic stem cells reduce porcine islet immunoreactivity in vitro and slow xeno-rejection in a murine model of islet transplantation.

Treatment of type 2 diabetes: future approaches.

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.

Metformin: historical overview.

Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels.

Metformin and the gastrointestinal tract.

Under-treatment of type 2 diabetes: Causes and outcomes of clinical inertia.

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Ageing, adipose tissue, fatty acids and inflammation.

Low gravity rotational culture and the integration of immunomodulatory stem cells reduce human islet allo-reactivity.

FDA guidance on cardiovascular risk of antidiabetic therapies: One decade later.